The clinical trials landscape will continue evolving toward greater decentralization, enhance patient-centricity, and increased global diversification. Industry projections suggest that by 2025, ...
Opinion

Can the Counterculture Rise Again?

Donald Trump and tech billionaires have killed the counterculture that thrived in past eras of protest. Can today's artists lead the resistance again?